Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial
Titel:
Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial
Auteur:
Nanchahal, Jagdeep Ball, Catherine Rombach, Ines Williams, Lynn Kenealy, Nicola Dakin, Helen O'Connor, Heather Davidson, Dominique Werker, Paul Dutton, Susan J Feldmann, Marc Lamb, Sarah E
Verschenen in:
The Lancet. Rheumatology
Paginering:
Jaargang 4 () nr. 6 pagina's e407-e416
Jaar:
2022
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license